Cargando…
Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)
BACKGROUND: Recent clinical trials demonstrate the feasibility of neoadjuvant immuno(chemo)therapy and report high rates of pathological remission, a surrogate marker for overall survival. PATIENTS AND METHODS: This is a retrospective multicentre real-world analysis of patients with locally resectab...
Autores principales: | Faehling, Martin, Witte, Hanno, Sebastian, Martin, Ulmer, Matthias, Sätzler, Rainer, Steinestel, Konrad, Brückl, Wolfgang M., Evers, Georg, Büschenfelde, Christian Meyer zum, Bleckmann, Annalen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958675/ https://www.ncbi.nlm.nih.gov/pubmed/35356258 http://dx.doi.org/10.1177/17588359221085333 |
Ejemplares similares
-
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
por: Gillen, Sonja, et al.
Publicado: (2010) -
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
por: Englmeier, Fabienne, et al.
Publicado: (2022) -
Impact of pre-OP independence in patients with limited brain metastases on long-term survival
por: Bleckmann, Annalen, et al.
Publicado: (2020) -
The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990) -
To treat or not to treat: A rare case of response to pembrolizumab‐based immunotherapy‐chemotherapy in non‐small cell lung cancer with acute liver failure due to multiple bile duct metastases
por: Shaforostova, Inna, et al.
Publicado: (2020)